REUTERS: Britain's GSK said on Wednesday it expects full-year adjusted earnings to be at the lower end of its forecast as the COVID-19 pandemic disrupts vaccination rates, especially for its blockbuster shingles vaccine.
The world's largest vaccine maker now expects 2020 profit to be at the lower end of its forecast of a 1per cent-4per cent drop, which did not include any potential impact from the coronavirus crisis.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Sumber: ChannelNewsAsia - 🏆 6. / 66 Baca lebih lajut »